z-logo
open-access-imgOpen Access
How long should we continue clomiphene citrate in anovulatory women?
Author(s) -
N. S. Weiss,
S. C. Braam,
T. E. Konig,
M. L. Hendriks,
C.J.C.M. Hamilton,
J Smeenk,
C.A.M. Koks,
Eugenie M. Kaaijk,
P. G. A. Hompes,
Cornelis B. Lambalk,
Fulco van der Veen,
B.W. Mol,
Madelon van Wely
Publication year - 2014
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deu215
Subject(s) - anovulation , medicine , pregnancy , gynecology , pregnancy rate , retrospective cohort study , obstetrics , incidence (geometry) , cumulative incidence , fertility , gestation , randomized controlled trial , cohort , population , polycystic ovary , biology , insulin resistance , physics , environmental health , insulin , optics , genetics
What is the effectiveness of continued treatment with clomiphene citrate (CC) in women with World Health Organization (WHO) type II anovulation who have had at least six ovulatory cycles with CC but did not conceive?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom